Could shorter antibiotic courses be safer for ventilator pneumonia?

NCT ID NCT05545735

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether giving antibiotics for 4 days instead of the usual 7 days is safe and effective for patients with ventilator-associated pneumonia (VAP). The goal was to reduce side effects from antibiotics while still treating the infection. The trial was stopped early after enrolling only 27 surgical patients, so the findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

antibiotics

What this could lead to

If successful, this could show that a shorter course of antibiotics is safe and effective for early ventilator-associated pneumonia, reducing side effects and antibiotic resistance.

What could go wrong

The trial was terminated early with only 27 participants, so results are limited and may not be reliable. Shorter treatment might not clear the infection in all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTILATOR ASSOCIATED PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pneumonia, Ventilator-Associated

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Jackson Memorial Hospital

    Miami, Florida, 33136, United States